date,title,source
Oct-30-18,Mustang Bio Announces Updates on CAR T Cell Therapy Clinical Trials with City of Hope,GlobeNewswire
Nov-13-18,Mustang Bio Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights,GlobeNewswire
Nov-19-18,"Investor Expectations to Drive Momentum within Lawson Products, Kingold Jewelry, Liberty Broadband, Mustang Bio, Artesian Resources, and MYnd Analytics  Discovering Underlying Factors of Influence",GlobeNewswire
Nov-28-18,Mustang Bio Announces Presentation of MB-102 (CD123 CAR) Safety and Efficacy Data at AACR Special Conference on Tumor Immunology and Immunotherapy,GlobeNewswire
Dec-17-18,MBIO: Mustang: A Steed on the Fast Track,Zacks Small Cap Research
Dec-20-18,"Need To Know: Mustang Bio, Inc. (NASDAQ:MBIO) Insiders Have Been Buying Shares",Simply Wall St.
Dec-20-18,Mustang Bio Receives Orphan Drug Designation for MB-102 (CD123 CAR T) for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm,GlobeNewswire
Feb-20-19,Mustang Bio and Nationwide Childrens Hospital Enter into Exclusive Worldwide License Agreement for Oncolytic Virus (C134) to Treat Glioblastoma Multiforme,GlobeNewswire
Mar-13-19,Mustang Bio to Present at Oppenheimers 29th Annual Healthcare Conference,GlobeNewswire
Mar-18-19,Mustang Bio Reports Full-Year 2018 Financial Results and Recent Corporate Highlights,GlobeNewswire
Apr-01-19,Mustang Bio Announces $20 Million Venture Debt Financing Agreement with Horizon Technology Finance,GlobeNewswire
Apr-09-19,Mustang Bio to Present at the World Orphan Drug Congress USA 2019,GlobeNewswire
Apr-17-19,Mustang Bio Soars 485% After Its Novel Gene Therapy Cured Bubble Boys,Bloomberg
Apr-17-19,St. Jude Childrens Research Hospital publishes results of Lentiviral Gene Therapy for Treatment of Infants with X-linked Severe Combined Immunodeficiency in New England Journal of Medicine,GlobeNewswire
Apr-17-19,St. Jude develops cure for bubble boy disease,American City Business Journals
